Pharmacy Times: What are some of the key benefits of detecting T1D before symptoms appear or insulin dependence begins? Shara Bialo, MD: Unfortunately, there are tons of people diagnosed with…
Pharmacy Times: Can you introduce yourself? Shara Bialo, MD: Thanks for having me. My name is Shara Bialo. I’m one of the senior medical directors of T1D Immunology at Sanofi.…
August 16, 2024 2 minute read Add topics to email alerts Receive an email when a new article is posted Enter your email address to receive…
(WHTM) — The U.S. Preventive Services Task Force recently updated its breast cancer screening guidelines. The latest change is that women should start having mammograms every two years starting at…
Teplizumab (Tzield, Sanofi) may delay the onset of type 1 diabetes (T1D), but barriers to treatment may affect adherence to the medication. Increased screening opportunities and education about these programs…
Type 1 diabetes (T1D) is currently not preventable or treatable, and its exact causes are still unknown, but amazing advances in medical technology and science are making it easier than…
A regional study has found that saliva-based screening can be leveraged to determine genetic risk scores for developing type 1 diabetes (T1D). Research results were published in Genome Medicine. The…
Toronto, February 20, 2024 /CNW/ – JDRF and Sanofi Canada have announced a partnership aimed at raising awareness of the chronic autoimmune disease type 1 diabetes (T1D) and the role…